NCT01128179 - Effects of Lanthanum Carbonate on FGF-23 in Subjects With Stage 3 CKD | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 6, 2010

Primary Completion Date

April 16, 2012

Study Completion Date

April 16, 2012

Conditions

Chronic Kidney Disease

Interventions

DRUG

Lanthanum carbonate

1000 mg in chewable tablets administered three times a day (for a total of 3000 mg/day) for 12 weeks

DRUG

Placebo

Matching placebo chewable tablets administered 3 times a day for 12 weeks

Trial Locations (1)

Dr Pablo Urena Torres, Saint-Ouen